TWST: Twist Bioscience Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,847.21
Enterprise Value ($M) 1,636.78
Book Value ($M) 440.11
Book Value / Share 7.35
Price / Book 4.20
NCAV ($M) 182.94
NCAV / Share 3.05
Price / NCAV 10.10

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 4.24
Current Ratio 4.51

Balance Sheet (mrq) ($M)
Current Assets 338.44
Assets 595.62
Liabilities 155.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 312.97
Operating Income -175.90
Net Income -208.73
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -64.09
Cash from Investing -3.07
Cash from Financing 6.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13G William Blair Investment Management, Llc 6.40 29.06
04-17 13G/A BlackRock, Inc. 8.30 -17.13
03-07 13G/A ARK Investment Management LLC 10.70 19.11
02-05 13G State Street Corp 4.30 -24.34
11-08 13G Invesco Ltd. 6.30
11-08 13G/A Nikko Asset Management Americas, Inc. 4.88 -20.16
11-05 13G/A Sumitomo Mitsui Trust Holdings, Inc. 4.88 -20.16
08-09 13G/A Jpmorgan Chase & Co 4.30 -43.77
07-09 13G/A Artisan Partners Limited Partnership 10.40 62.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-03 10-Q * * * * *
2024-11-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 183,071 972,954 18.82
2025-05-08 126,251 909,988 13.87
2025-05-07 156,179 1,021,225 15.29
2025-05-06 299,375 1,796,975 16.66
2025-05-05 383,390 1,931,944 19.84

(click for more detail)

Similar Companies
TRML – Tourmaline Bio, Inc. TSHA – Taysha Gene Therapies, Inc.
TSVT – 2seventy bio, Inc. TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io